文献速递消化道肿瘤与早癌消化内镜

加拿大早发性结直肠癌的发病率、分期与死亡率:对人群筛查的启示

Early-Onset Colorectal Cancer Incidence, Staging, and Mortality in Canada: Implications for Population-Based Screening.
PubMed 文献 · Am J Gastroenterol · 2022-06-10

该研究基于加拿大癌症登记和生命统计数据分析2000-2017年结直肠癌发病率和2000-2018年死亡率。结果显示20-49岁人群结直肠癌发病率在远端结肠和直肠显著上升,30-49岁成人确诊时晚期风险高于50-74岁人群,直肠癌死亡率在早发组上升。作者认为新数据支持未来修改加拿大早发性结直肠癌筛查指南,但需进一步研究靶向筛查的效果、成本效益和风险预测。

要点

  • 20-49岁女性远端结肠和直肠癌发病率显著上升,男性近端结肠、远端结肠和直肠癌发病率显著上升。
  • 30-49岁成人确诊结直肠癌时晚期风险显著高于50-74岁人群。
  • 2000-2018年早发组直肠癌死亡率上升,女性APC为3.80,男性APC为3.40。

核心结论

  • 新出现的证据支持未来修改加拿大早发性结直肠癌筛查指南。
  • 需要对这一群体中靶向筛查的效果、成本效益和风险预测进行进一步研究。

研究设计与样本

  • 研究数据来自加拿大癌症登记和生命统计,结直肠癌发病率数据为2000-2017年,死亡率数据为2000-2018年。
  • 使用joinpoint回归估计早发性结直肠癌发病率(按部位和组织学)和死亡率的年度百分比变化(APC)。
  • 使用泊松回归比较早发性结直肠癌组(20-49岁)与符合筛查条件组(50-74岁)的晚期(III或IV期)与早期(I或II期)结直肠癌发病率。

主要发现

  • 20-49岁女性结直肠癌发病率在远端结肠(APC=1.40)和直肠(APC=3.00)显著上升。
  • 20-49岁男性结直肠癌发病率在近端结肠(APC=1.10)、远端结肠(APC=3.00)和直肠(APC=3.70)上升。
  • 20-49岁男性和女性非黏液性腺癌发病率显著上升(APC分别为1.90和2.30),女性黏液性腺癌发病率下降(APC=-1.60),男性保持稳定。
  • 30-49岁成人确诊结直肠癌时晚期风险显著高于50-74岁人群。
  • 2000-2018年早发性结直肠癌组直肠癌死亡率上升,女性和男性APC分别为3.80和3.40。

局限性

  • 需要进一步研究靶向筛查的效果、成本效益和风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The incidence of early-onset colorectal cancer (eoCRC) has been increasing in North America. Debate remains as to whether the trends by topography, histology, stage, or mortality in this population are amenable to intervention from screening. METHODS: CRC incidence (2000-2017) and mortality (2000-2018) data were obtained from the Canadian Cancer Registry and Vital Statistics. Annual percentage changes (APC) in the incidence (topography and histology) and mortality of eoCRC were estimated using joinpoint regression. Incidence of late-stage CRC (III or IV) versus early-stage CRC (I or II) was compared between the eoCRC (age 20-49 years) and eligible screening (age 50-74 years) groups with Poisson regression. RESULTS: Among women aged 20-49 years, the incidence of CRC significantly increased from 2000 to 2017 in both the distal colon (APC = 1.40) and rectum (APC = 3.00), whereas for men aged 20-49 years, the CRC incidence increased in the proximal colon (APC = 1.10), distal colon (APC = 3.00), and rectum (APC = 3.70). Among both men and women aged 20-49 years, the incidence of nonmucinous adenocarcinomas significantly increased (APC: 1.90 and 2.30, respectively), whereas mucinous adenocarcinomas decreased for women (APC = -1.60) and remained stable for men. Adults aged 30 to 49 years, when diagnosed with CRC, had a significantly higher risk of being diagnosed with a late-stage CRC compared with those in the age group of 50-74 years. Rectal cancer mortality increased from 2000 to 2018 in the eoCRC group (APC for women and men 3.80 and 3.40, respectively). DISCUSSION: Emerging data support future modifications to guidelines on screening for eoCRC in Canada. Further research is required on the effect, cost-effectiveness, and risk prediction for targeted screening within this group.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. O'Sullivan DE, Ruan Y, Cheung WY, et al. Early-Onset Colorectal Cancer Incidence, Staging, and Mortality in Canada: Implications for Population-Based Screening. Am J Gastroenterol. 2022. PMID: 35973186. doi:10.14309/ajg.0000000000001884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。